Fortress Biotech (FBIO) Revenue (2015 - 2026)

Fortress Biotech's Revenue history runs 11 years deep, the most recent figure standing at $14.1 million for Q4 2025.

• In Q4 2025, Revenue fell 7.29% year-over-year to $14.1 million; the TTM figure through Dec 2025 stood at $59.8 million (up 3.67% YoY), while the FY2025 annual figure was $61.2 million, up 6.18% from the prior year.
• Revenue for Q4 2025 stood at $14.1 million, down from $17.6 million in the prior quarter.
• The five-year high for Revenue was $58.5 million in Q4 2021, with the low at -$57.5 million in Q4 2022.
• The 5-year median for Revenue is $13.6 million (2025), against an average of $9.3 million.
• Peak annual rise in Revenue reached 11664.52% in 2022, while the deepest fall reached 198.24% in 2022.
• Fortress Biotech's Revenue stood at $58.5 million in 2021, then tumbled by 198.24% to -$57.5 million in 2022, then surged by 126.55% to $15.3 million in 2023, then slipped by 0.63% to $15.2 million in 2024, then slipped by 7.29% to $14.1 million in 2025.
• Business Quant data shows FBIO's Revenue at $14.1 million in Q4 2025, $17.6 million in Q3 2025, and $15.0 million in Q2 2025.